136 related articles for article (PubMed ID: 29101445)
1. Integrated
Cho N; Im SA; Cheon GJ; Park IA; Lee KH; Kim TY; Kim YS; Kwon BR; Lee JM; Suh HY; Suh KJ
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):328-339. PubMed ID: 29101445
[TBL] [Abstract][Full Text] [Related]
2. Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer.
Kazerouni AS; Peterson LM; Jenkins I; Novakova-Jiresova A; Linden HM; Gralow JR; Hockenbery DM; Mankoff DA; Porter PL; Partridge SC; Specht JM
Breast Cancer Res; 2023 Nov; 25(1):138. PubMed ID: 37946201
[TBL] [Abstract][Full Text] [Related]
3.
Diwanji D; Onishi N; Hathi DK; Lawhn-Heath C; Kornak J; Li W; Guo R; Molina-Vega J; Seo Y; Flavell RR; Heditsian D; Brain S; Esserman LJ; Joe BN; Hylton NM; Jones EF; Ray KM
Radiol Imaging Cancer; 2024 Mar; 6(2):e230082. PubMed ID: 38551406
[TBL] [Abstract][Full Text] [Related]
4. Intra and peritumoral PET radiomics analysis to predict the pathological response in breast cancer patients receiving neoadjuvant chemotherapy.
Aksu A; Güç ZG; Küçüker KA; Alacacıoğlu A; Turgut B
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(3):500002. PubMed ID: 38527731
[TBL] [Abstract][Full Text] [Related]
5. Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [
Jannusch K; Dietzel F; Bruckmann NM; Morawitz J; Boschheidgen M; Minko P; Bittner AK; Mohrmann S; Quick HH; Herrmann K; Umutlu L; Antoch G; Rubbert C; Kirchner J; Caspers J
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1451-1461. PubMed ID: 38133687
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers from in vivo molecular imaging of breast cancer: pretreatment
Gallivanone F; Panzeri MM; Canevari C; Losio C; Gianolli L; De Cobelli F; Castiglioni I
MAGMA; 2017 Aug; 30(4):359-373. PubMed ID: 28246950
[TBL] [Abstract][Full Text] [Related]
7. Value of Dynamic
Kupik O; Tuncel M; Özgen Kıratlı P; Akpınar MG; Altundağ K; Başaran Demirkazık F; Erbaş B
Mol Imaging Radionucl Ther; 2023 Jun; 32(2):94-102. PubMed ID: 37337702
[TBL] [Abstract][Full Text] [Related]
8. Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI.
Cao Y; Wang X; Li L; Shi J; Zeng X; Huang Y; Chen H; Jiang F; Yin T; Nickel D; Zhang J
Diagn Interv Imaging; 2023 Dec; 104(12):605-614. PubMed ID: 37543490
[TBL] [Abstract][Full Text] [Related]
9. Multi-parametric MRI in the early prediction of response to neo-adjuvant chemotherapy in breast cancer: Value of non-modelled parameters.
O'Flynn EA; Collins D; D'Arcy J; Schmidt M; de Souza NM
Eur J Radiol; 2016 Apr; 85(4):837-42. PubMed ID: 26971432
[TBL] [Abstract][Full Text] [Related]
10. Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer.
Ren Z; Pineda FD; Howard FM; Fan X; Nanda R; Abe H; Kulkarni K; Karczmar GS
Magn Reson Imaging; 2023 Dec; 104():9-15. PubMed ID: 37611646
[TBL] [Abstract][Full Text] [Related]
11. Time Course Changes of Synthetic Relaxation Time During Neoadjuvant Chemotherapy in Breast Cancer: The Optimal Parameter for Treatment Response Evaluation.
Zhao R; Du S; Gao S; Shi J; Zhang L
J Magn Reson Imaging; 2023 Oct; 58(4):1290-1302. PubMed ID: 36621982
[TBL] [Abstract][Full Text] [Related]
12. Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy.
Malhaire C; Selhane F; Saint-Martin MJ; Cockenpot V; Akl P; Laas E; Bellesoeur A; Ala Eddine C; Bereby-Kahane M; Manceau J; Sebbag-Sfez D; Pierga JY; Reyal F; Vincent-Salomon A; Brisse H; Frouin F
Eur Radiol; 2023 Nov; 33(11):8142-8154. PubMed ID: 37318605
[TBL] [Abstract][Full Text] [Related]
13. Prediction of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer by using a deep learning model with 18F-FDG PET/CT.
Bulut G; Atilgan HI; Çınarer G; Kılıç K; Yıkar D; Parlar T
PLoS One; 2023; 18(9):e0290543. PubMed ID: 37708209
[TBL] [Abstract][Full Text] [Related]
14. The role of PET and MRI in evaluating the feasibility of skin-sparing mastectomy following neoadjuvant therapy.
Malya FU; Kadioglu H; Bektasoglu HK; Gucin Z; Yildiz S; Guzel M; Erdogan EB; Yucel S; Ersoy YE
J Int Med Res; 2018 Feb; 46(2):626-636. PubMed ID: 29332418
[TBL] [Abstract][Full Text] [Related]
15. Prediction of pathological complete response of breast cancer patients who received neoadjuvant chemotherapy with a nomogram based on clinicopathologic variables, ultrasound, and MRI.
Zhang MQ; Liu XP; Du Y; Zha HL; Zha XM; Wang J; Liu XA; Wang SJ; Zou QG; Zhang JL; Li CY
Br J Radiol; 2024 Jan; 97(1153):228-236. PubMed ID: 38263817
[TBL] [Abstract][Full Text] [Related]
16. Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment.
Onishi N; Bareng TJ; Gibbs J; Li W; Price ER; Joe BN; Kornak J; Esserman LJ; Newitt DC; Hylton NM; ;
Radiol Imaging Cancer; 2023 Jul; 5(4):e220126. PubMed ID: 37505107
[TBL] [Abstract][Full Text] [Related]
17. Can peritumoral edema evaluated by Magnetic Resonance Imaging before neoadjuvant chemotherapy predict complete pathological response in breast cancer?
Cakir Pekoz B; Dilek O; Koseci T; Tas ZA; Irkorucu O; Gulek B
Scott Med J; 2023 Aug; 68(3):121-128. PubMed ID: 37161314
[TBL] [Abstract][Full Text] [Related]
18. Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial.
Onishi N; Li W; Gibbs J; Wilmes LJ; Nguyen A; Jones EF; Arasu V; Kornak J; Joe BN; Esserman LJ; Newitt DC; Hylton NM
Tomography; 2020 Jun; 6(2):77-85. PubMed ID: 32548283
[TBL] [Abstract][Full Text] [Related]
19. Comparison of MRI vs. [
Caracciolo M; Castello A; Urso L; Borgia F; Marzola MC; Uccelli L; Cittanti C; Bartolomei M; Castellani M; Lopci E
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629397
[TBL] [Abstract][Full Text] [Related]
20. Deep Learning of Multimodal Ultrasound: Stratifying the Response to Neoadjuvant Chemotherapy in Breast Cancer Before Treatment.
Gu J; Zhong X; Fang C; Lou W; Fu P; Woodruff HC; Wang B; Jiang T; Lambin P
Oncologist; 2024 Feb; 29(2):e187-e197. PubMed ID: 37669223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
